Risk factors and outcomes associated with anastomotic leaks following esophagectomy: a systematic review and meta-analysis
SK Kamarajah, A Lin, T Tharmaraja… - Diseases of the …, 2020 - academic.oup.com
Anastomotic leaks (AL) are a major complication after esophagectomy. This meta-analysis
aimed to determine identify risks factors for AL (preoperative, intra-operative, and post …
aimed to determine identify risks factors for AL (preoperative, intra-operative, and post …
Current status and application of proton therapy for esophageal cancer
X Wang, B Hobbs, SJ Gandhi, CT Muijs… - Radiotherapy and …, 2021 - Elsevier
Esophageal cancer remains one of the leading causes of death from cancer across the
world despite advances in multimodality therapy. Although early-stage disease can often be …
world despite advances in multimodality therapy. Although early-stage disease can often be …
Geriatric Radiation Oncology: What We Know and What Can We Do Better?
F Roeder, AD Jensen, K Lindel, M Mattke… - … Interventions in Aging, 2023 - Taylor & Francis
Elderly patients represent a growing subgroup of cancer patients for whom the role of
radiation therapy is poorly defined. Older patients are still clearly underrepresented in …
radiation therapy is poorly defined. Older patients are still clearly underrepresented in …
Cardiotoxicity of radiation therapy in esophageal cancer
M Vošmik, M Hodek, D Buka… - Reports of Practical …, 2020 - journals.viamedica.pl
With a development of radiotherapeutic techniques, availability of radiotherapy data on
cardiotoxicity, and slowly improving esophageal cancer outcomes, an increasing emphasis …
cardiotoxicity, and slowly improving esophageal cancer outcomes, an increasing emphasis …
A multi-institutional analysis of radiation dosimetric predictors of toxicity after trimodality therapy for esophageal cancer
Purpose This multi-institutional review explored associations between radiation dose-
volume histogram (DVH) parameters and cardiopulmonary toxicities with trimodality therapy …
volume histogram (DVH) parameters and cardiopulmonary toxicities with trimodality therapy …
Definitive chemoradiotherapy versus trimodality therapy for resectable oesophageal carcinoma: meta‐analyses and systematic review of literature
DM Voeten, CM den Bakker… - World journal of …, 2019 - Wiley Online Library
Background Standard therapy for loco‐regionally advanced, resectable oesophageal
carcinoma is trimodality therapy (TMT) consisting of neoadjuvant chemoradiotherapy and …
carcinoma is trimodality therapy (TMT) consisting of neoadjuvant chemoradiotherapy and …
Executive summary of clinical and technical guidelines for esophageal cancer proton beam therapy from the Particle Therapy Co-Operative Group Thoracic and …
Radiation therapy (RT) is an integral component of potentially curative management of
esophageal cancer (EC). However, RT can cause significant acute and late morbidity due to …
esophageal cancer (EC). However, RT can cause significant acute and late morbidity due to …
The effect of surgery plus chemoradiotherapy on survival of elderly patients with stage Ⅱ–Ⅲ esophageal cancer: a SEER‐based demographic analysis
Background The optimal treatment for elderly patients with esophageal cancer (EC) remains
controversial. In the present study, we aimed to investigate whether elderly patients with …
controversial. In the present study, we aimed to investigate whether elderly patients with …
Patterns of care and outcomes of elderly esophageal cancer patients not meeting age-based criteria of the CROSS trial
V Verma, W Haque, D Zheng… - American Journal of …, 2019 - journals.lww.com
Objectives: The CROSS trial established neoadjuvant chemoradiation followed by surgery
(nCRT-S) as superior to surgery alone (S) for locally advanced esophageal cancer (EC) …
(nCRT-S) as superior to surgery alone (S) for locally advanced esophageal cancer (EC) …
[HTML][HTML] The emerging role of proton therapy for esophagus cancer
KR Jethwa, MG Haddock, EJ Tryggestad… - Journal of …, 2020 - ncbi.nlm.nih.gov
Chemoradiotherapy (CRT) plays an essential role in the treatment of esophageal cancer as
either curative or neoadjuvant therapy. When delivered with conventional photon-based …
either curative or neoadjuvant therapy. When delivered with conventional photon-based …